What do you think of Cynapsus Therapeutics whose research on a new drug delivery system for Parkinson desease is partially funded by the Michael J. Fox Foundation.
Read Answer
Asked by Michel L on November 24, 2014
Q: Hi Peter and Team,
I am currently holding GILD Gilead Sciences, CXR Concordia Healthcare and CCT Catamaran.
I am thinking to add one small cap of this sector into my p/f and am looking at GUD Knight Therapeutic and PLI ProMetic Life Science. Which one would you recommend. If you do not these two, pls suggest another one.
Q: Just read an article about Dollarama. I would appreciate your comments re investment over 3 to 5 years, Thank you for your great independent advice. Much appreciated. Keith
Q: I bought this stock a month ago and have a small position and it was my intention to purchase more shares later by dollar cost averaging. I wasn't planning on doing this so quickly but with the recent down grade by Credit Suisse on this company and the price drop in the past few days, would you consider this to be a good time to increase my position. As they are reporting earnings on the 25th could the recent downgrade be attributed to speculation to a possible poorer result and if that is the case would I be better to wait until after the earnings report.
Q: In spite of the much improved 2015 Q1 operating results over 2014 Q1, LMP's stock price had dropped from its highs in August/September by some 40% by early November (although it has a major rally over the last week or so but still down significantly from its highs). Your comments on this company going forward would be much appreciated.
Q: I just heard on BNN that someone (didn't catch which brokerage) had just downgraded atd.b which I hold and have done well with, to a SELL. Kind of shocked at that. What do you make of it. Real Bad News to come??? or what
Thank you Peter and Staff for all you do.
I have learned a lot from your site.
Q: Prometic Life Sciences (PLI) has gone up from $!.60 in the last short while to as high as $2.20 and now they are doing a $25M financing. I tried to buy 25,000 shares and received zero! Is this stock a little expensive or would you buy it and hold for three years?
Thanks.
Q: knight sold their FDA voucher to Gilead for 125 mil US. This just reinforces my view that you want to stay with this mgt. team for the long haul. your comments please.
Q: I've held this stock for the past couple of years and am pleased it's performed so well. With it having hit annual/lifetime highs is it too late to purchase more? What do you see as it's future prospects and do you plan on writing a report on it anytime?
Thanks!
Q: I've started to follow this stock recently after I read about it on BNN. What are your thoughts on the management, product offerings and future.
Thx
Jim
Q: I'm looking at investing in a high potential growth stock in pharmaceuticals with a 5 year time horizon. I have narrowed it to three, GUD, Merus (MLS) or Cipher (DND). How would you rank these three as choices one to three. Any others to consider?
Thanks
Jim
Q: Hi, I wonder if you could explain the outperformance of adw.b vs adw.a. I have owned the a shares for a couple of years and while not disappointed I am wondering what it would take to get this somewhat "constipated" stock moving. Thank you very much.